BridgeBio Pharma BBIO Price Prediction

The determination to procure BridgeBio Pharma is entirely contingent on your individualistic risk tolerance. As you may discern, BridgeBio Pharma's value has experienced an escalation of 5.97% during the preceding 24 hours, and BridgeBio Pharma has incurred a decline of -9.63% over the prior 30-day duration. Consequently, the determination of whether or not to invest in BridgeBio Pharma will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of BridgeBio Pharma may potentially surge to $78.32 by the end of this year. Looking at BridgeBio Pharma's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $73.29. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental BridgeBio Pharma forecast, the price of BridgeBio Pharma will increase by 2.24% over the next week and reach $76.63 by November 9, 2026.

Based on the our new experimental BridgeBio Pharma forecast, the price of BridgeBio Pharma will increase by 2.67% over the next month and reach $76.95 by December 2, 2026.

As per our most recent prediction on BridgeBio Pharma's value in 2026, BBIO is anticipated to fluctuate within the range of $75.16 and $78.32. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected BridgeBio Pharma price forecast fails to consider sudden and extreme price fluctuations.

BridgeBio Pharma's future appears to be on an upward trend, with an maximum price of $73.29 projected after a period of five years. Based on the BridgeBio Pharma forecast for 2031, BridgeBio Pharma's value may potentially reach its highest peak of approximately $73.29, while its lowest peak is anticipated to be around $66.57.

Based on the our new experimental BridgeBio Pharma price prediction simulation, BBIO’s value in 2026 expected to grow by 4.51% to $78.32 if the best happened. The price will be between $78.32 and $75.16 during 2026.

According to our latest experimental simulation for BridgeBio Pharma price prediction, BBIO’s value could rise by 9.29% to $81.91 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $81.91 and $65.79 throughout the year.

Our new experimental BridgeBio Pharma price prediction model suggests that BBIO’s value in 2028 could down by -7.55%, reaching $69.29 in the best-case scenario. The price is expected to range between $69.29 and $52.35 during the year.

Based on our experimental forecast model, BridgeBio Pharma's value may experience a -17.52% fall in 2029, potentially reaching $61.81 under optimal conditions. The predicted price range for 2029 lies between $61.81 and $52.51.

Using our new experimental simulation for BridgeBio Pharma price predictions, BBIO’s value in 2030 is expected to down by -4.93%, reaching $71.25 in the best scenario. The price is forecasted to range between $71.25 and $55.49 over the course of 2030.

Our experimental simulation indicates that BridgeBio Pharma’s price could down by -2.21% in 2031, potentially hitting $73.29 under ideal conditions. The price will likely fluctuate between $73.29 and $66.57 during the year.

Based on the findings from our latest experimental BridgeBio Pharma price prediction, BBIO could see a 14.02% rise in value, reaching $85.45 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $85.45 and $71.42 throughout the year.

According to our experimental BridgeBio Pharma price prediction, BBIO’s value is anticipated to rise by 40.39% in 2033, with the highest potential price being $105.22. Throughout the year, BBIO’s price could range from $105.22 and $85.64.

The results from our new BridgeBio Pharma price prediction simulation suggest that BBIO may rise by 58.94% in 2034, potentially reaching $119.12 under the best circumstances. The predicted price range for the year is between $119.12 and $101.82.

Based on our experimental forecast for BridgeBio Pharma’s price, BBIO could grow by 92.57% , with the value potentially hitting $144.32 in 2035. The expected price range for the year lies between $144.32 and $112.82.

Our recent BridgeBio Pharma price prediction simulation suggests that BBIO’s value might rise by 155.5% in 2036, possibly reaching $191.50 if conditions are optimal. The expected price range for 2036 is between $191.50 and $137.94.

According to the experimental simulation, BridgeBio Pharma’s value could rise by 216.87% in 2037, with a high of $237.49 under favorable conditions. The price is expected to fall between $237.49 and $188.63 over the course of the year.